TY  - GEN
AU  - Gutierrez-Valencia, Alicia
AU  - Trujillo-Rodriguez, Maria
AU  - Fernandez-Magdaleno, Tamara
AU  - Espinosa, Nuria
AU  - Viciana, Pompeyo
AU  - López-Cortés, Luis F
PY  - 2018
DO  - 10.1002/jia2.25072
UR  - https://hdl.handle.net/20.500.12105/25242
AB  - Introduction: When darunavir (DRV) 800 mg is boosted with 150 mg cobicistat (DRVcobi), DRV trough concentration (Ctrough) is about 30% lower as compared to 100 mg ritonavir (DRVrtv). DRVcobi shows similar virological efficacy as DRVrtv when combined...
LA  - eng
KW  - Ctrough
KW  - Darunavir
KW  - Cobicistat
KW  - Monotherapy
KW  - Pharmacokinetic
KW  - Ritonavir
KW  - Adult
KW  - Anti-HIV Agents
KW  - Cobicistat
KW  - Darunavir
KW  - Drug Therapy, Combination
KW  - Female
KW  - HIV Infections
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Reverse Transcriptase Inhibitors
KW  - Ritonavir
KW  - Viral Load
TI  - Darunavir/cobicistat showing similar effectiveness as darunavir/ritonavir monotherapy despite lower trough concentrations.
TY  - research article
ER  -